Search

Sanna Rosengren Phones & Addresses

  • 150 Rodney Ave, Encinitas, CA 92024
  • 802 Appleridge Dr, Encinitas, CA 92024
  • 3019 Pueblo St, Carlsbad, CA 92009
  • Cardiff by the Sea, CA
  • San Diego, CA

Work

Company: Halozyme therapeutics, inc. Feb 2012 Address: San Diego, CA Position: Principal scientist, bioanalytical

Education

Degree: PhD School / High School: Uppsala University 1986 to 1991 Specialities: Immunology and Physiology

Skills

Immunology • Assay Development • In Vivo • Animal Models • Life Sciences • Cancer • Elisa • Biomarkers • Cell • Drug Discovery • Biotechnology • Translational Research • Statistics • Qpcr • Clinical Trials • Pharmaceutical Industry • Cell Biology • Immunogenicity • Antibodies

Languages

English • Swedish

Interests

Vocals • Amateur Musician

Industries

Biotechnology

Resumes

Resumes

Sanna Rosengren Photo 1

Founder

View page
Location:
150 Rodney Ave, Encinitas, CA 92024
Industry:
Biotechnology
Work:
Halozyme Therapeutics, Inc. - San Diego, CA since Feb 2012
Principal Scientist, Bioanalytical

Rosengren Research Consulting Oct 2011 - Feb 2012
Consultant, Immunology/Biostatistics

University of California, San Diego - Greater San Diego Area Aug 2001 - Oct 2011
Project Scientist

Metabasis Therapeutics - Greater San Diego Area 1993 - 2001
Senior Scientific Investigator

Cytel Corporation - Greater San Diego Area Jan 1992 - Jan 1993
Staff Scientist
Education:
Uppsala University 1986 - 1991
PhD, Immunology and Physiology
Uppsala University 1981 - 1984
Bachelor of Science, Physiology/Immunology
Skills:
Immunology
Assay Development
In Vivo
Animal Models
Life Sciences
Cancer
Elisa
Biomarkers
Cell
Drug Discovery
Biotechnology
Translational Research
Statistics
Qpcr
Clinical Trials
Pharmaceutical Industry
Cell Biology
Immunogenicity
Antibodies
Interests:
Vocals
Amateur Musician
Languages:
English
Swedish

Publications

Us Patents

Compositions And Methods For Treating Nrp2-Associated Diseases

View page
US Patent:
20230039401, Feb 9, 2023
Filed:
Jun 15, 2022
Appl. No.:
17/841187
Inventors:
- San Diego CA, US
Kathleen M. OGILVIE - San Diego CA, US
Suzanne PAZ - San Marcos CA, US
Sanna ROSENGREN - Encinitas CA, US
Kaustubh DATTA - Omaha NE, US
International Classification:
A61K 38/53
A61P 29/00
Abstract:
Provided are therapies, including standalone and combination therapies, for treating neuropilin-2 (NRP2)-associated diseases and conditions, which include the use of at least one histidyl-tRNA synthetase (HRS) polypeptide.

Compositions And Methods For Treating Nrp2-Associated Diseases

View page
US Patent:
20200085925, Mar 19, 2020
Filed:
Jul 26, 2019
Appl. No.:
16/523783
Inventors:
- San Diego CA, US
Kathleen M. Ogilvie - San Diego CA, US
Suzanne Paz - San Marcos CA, US
Sanna Rosengren - Encinitas CA, US
Kaustubh Datta - Omaha NE, US
International Classification:
A61K 38/53
A61P 29/00
Abstract:
Provided are therapies, including standalone and combination therapies, for treating neuropilin-2 (NRP2)-associated diseases and conditions, which include the use of at least one histidyl-tRNA synthetase (HRS) polypeptide.
Sanna E Rosengren from Encinitas, CA, age ~61 Get Report